Ganciclovir

BreastfeedingGeriatricPediatric
  • TRADE NAMES: Cymevan; Cymeven; Cymevene; Cytovene (Roche); Vitrasert
  • INDICATIONS: Cytomegalovirus retinitis in immunocompromised patients
  • CLASS: Antiviral, Guanine nucleoside analog
  • HALF-LIFE: 2.5–3.6 hours
GRANULOCYTOPENIA, ANEMIA AND THROMBOCYTOPENIA

See full prescribing information for complete boxed warning.

Our database has 43 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
HAIR.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
HEMATOLOGIC.
LOCAL.
NEUROMUSCULAR/SKELETAL.
OCULAR.


Page last updated 09/03/2019

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top